Clinical validation of engineered CRISPR/Cas12a for rapid SARS-CoV-2 detection

BACKGROUND: The coronavirus disease (COVID-19) caused by SARS-CoV-2 has swept through the globe at an unprecedented rate. CRISPR-based detection technologies have emerged as a rapid and affordable platform that can shape the future of diagnostics. METHODS: We developed ENHANCEv2 that is composed of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Long T., Rananaware, Santosh R., Pizzano, Brianna L. M., Stone, Brandon T., Jain, Piyush K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053293/
https://www.ncbi.nlm.nih.gov/pubmed/35603267
http://dx.doi.org/10.1038/s43856-021-00066-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053293/
https://www.ncbi.nlm.nih.gov/pubmed/35603267
http://dx.doi.org/10.1038/s43856-021-00066-4

Ejemplares similares